News of Note—Silkworms for drug delivery; immunotherapy in bladder cancer – FierceBiotech
FierceBiotech |
News of Note—Silkworms for drug delivery; immunotherapy in bladder cancer
FierceBiotech News of Note—Silkworms for drug delivery; immunotherapy in bladder cancer. by Arlene Weintraub |. Jul 24, 2017 11:05am. A drug capsule inspired by silkworm cocoons may improve drug delivery. (Natural Materials Group, Weizmann Institute of Science). |
PR Newswire (press release) |
‘Stem cell centers’ often deliver therapy for HF without preevaluations, follow-up
Healio While stem cell therapy for heart failure is still undergoing investigation by the FDA, a number of clinics are marketing the therapy directly to consumers, but a recent analysis published in JAMA Internal Medicine calls into question their medical … Breakthrough in Advanced Kidney Disease by Stem Cell Genetic MedPR Newswire (press release) Stem Cells Market By Global Manufacturers, Regions, Type And Application, Forecast To 2022Medgadget (blog) Revised draft National Guidelines for Stem Cell Research prohibits several areas of research in stem cellpharmabiz.com |
PR Newswire (press release) |
‘Stem cell centers’ often deliver therapy for HF without preevaluations, follow-up
Healio While stem cell therapy for heart failure is still undergoing investigation by the FDA, a number of clinics are marketing the therapy directly to consumers, but a recent analysis published in JAMA Internal Medicine calls into question their medical … Breakthrough in Advanced Kidney Disease by Stem Cell Genetic MedPR Newswire (press release) Stem Cells Market By Global Manufacturers, Regions, Type And Application, Forecast To 2022Medgadget (blog) Revised draft National Guidelines for Stem Cell Research prohibits several areas of research in stem cellpharmabiz.com |
|
Optimizing Cancer Immunotherapy Through Memory T Cell Collaboration
Specialty Pharmacy Times “Current immunotherapy is based the reactivation of these T lymphocytes; however, little is known about how they can be generated more effectively, and in particular how immune memory can be triggered to prevent the development of tumors and metastasis … |
Genetic Engineering & Biotechnology News |
Immunotherapy’s Ineffectiveness toward Bladder Cancer Uncovered
Genetic Engineering & Biotechnology News Checkpoint immunotherapy drugs have seen a surge in their adoption as their effectiveness in treating various cancers continues to provide clinical success. Yet, one type of persistent tumor has remained relatively intractable to immunotherapeutic … Immune cells the missing ingredient in new bladder cancer treatmentMedical Xpress |
|
4D Molecular Therapeutics and Foundation Fighting Blindness Partner to Develop Gene Therapies for Retinal Diseases
Business Wire (press release) EMERYVILLE, Calif. & COLUMBIA, Md.–(BUSINESS WIRE)–4D Molecular Therapeutics (4DMT), a leader in adeno-associated virus (AAV) gene therapy vector discovery and product development, and the Foundation Fighting Blindness (FFB), the world’s … |
Labiotech.eu (blog) |
British Biotech’s Gene Therapy for Rare ‘Bubble Baby’ Disease gets Fast-Tracked by the FDA
Labiotech.eu (blog) Orchard Therapeutics has received rare pediatric disease designation for OTL-101, a gene therapy for the treatment of the rare disease ADA-SCID. Orchard Therapeutics, launched just a year ago in London, is developing what could be a new version of … OTL-101 granted Rare Pediatric Disease designationThe Pharma Letter (registration) |